Regor Therapeutics Group

📍 Shanghai, China🗓 Founded 2018👥 30 employees💰 Last funded Feb 2021
Pharmaceutical Manufacturing🌐 regor.com
Website LinkedIn
Regor Therapeutics is a clinical stage company dedicated to the discovery and development of innovative and clinically differentiated medicines by leveraging the proprietary CARD (Computer Accelerated Rational Discovery) Platform. The company focuses mainly on three therapeutic areas, oncology, immunology, and metabolic disorders. By seamlessly integrating CARD with structural biology, computational chemistry, therapeutic biology, medicinal chemistry, and clinical development, Regor has successfully assembled a world-class scientific team and established a highly efficient new drug innovation engine to enable the discovery and development of best- and first-in-class molecules.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
China
2
Frequently asked questions
Who invested in Regor Therapeutics Group?
Regor Therapeutics Group has 2 investors on record on gritt.io, 2 mid-stage.
When did Regor Therapeutics Group last raise funding?
The most recent investment in Regor Therapeutics Group recorded on gritt.io was in February 2021.
When was Regor Therapeutics Group founded?
Regor Therapeutics Group was founded in 2018.
What industry is Regor Therapeutics Group in?
Regor Therapeutics Group operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Regor Therapeutics Group based?
Regor Therapeutics Group is headquartered in Shanghai, China.